Opaleye Management Inc. - 11 Sep 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Sep 2024, 20:20:11 UTC
Prior SEC filing
12 Sep 2024
Next SEC filing
19 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Opaleye Management Inc., By: /s/ James Silverman, President

Key filing fact

Opaleye Management Inc. filed Form 4 for Protara Therapeutics, Inc. (TARA) on 12 Sep 2024.

Key facts

  • This page summarizes Opaleye Management Inc.'s Form 4 filing for Protara Therapeutics, Inc. (TARA).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Sep 2024, 20:20.

Change

  • Previous filing in this sequence was filed on 12 Sep 2024.
  • Current net transaction value: -$271,715.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TARA transaction

Common Stock, par value $0.001 per share

Sale

Transaction value
$53,137
Shares
-31,000
Change %
-1.5%
Price
$1.71
Shares after
2,063,935
Date
11 Sep 2024
Ownership
By Opaleye, L.P.
Footnotes
F1, F3
TARA transaction

Common Stock, par value $0.001 per share

Sale

Transaction value
$2,743
Shares
-1,600
Change %
-3%
Price
$1.71
Shares after
51,500
Date
11 Sep 2024
Ownership
By Managed account
Footnotes
F2, F3
TARA transaction

Common Stock, par value $0.001 per share

Sale

Transaction value
$204,728
Shares
-119,801
Change %
-5.8%
Price
$1.71
Shares after
1,944,134
Date
12 Sep 2024
Ownership
By Opaleye, L.P.
Footnotes
F1, F4
TARA transaction

Common Stock, par value $0.001 per share

Sale

Transaction value
$11,108
Shares
-6,500
Change %
-13%
Price
$1.71
Shares after
45,000
Date
12 Sep 2024
Ownership
By Managed account
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Footnote F2

Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.74 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70-$1.75 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .